Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Sarilumab

Sarilumab

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Sarilumab

15 trials tracked of Sarilumab: 9 in phase 3 or 4 and 3 with published results. The most-cited published study has 43 citations.

15Trials tracked
9Phase 3 & 4
0Recruiting
3With published results
Phase distribution
Phase 4 1 Phase 3 8 Phase 2 6
  1. Phase 3 Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI Completed · 43 cited
  2. Phase 3 Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19 Completed · 41 cited
  3. Phase 3 Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors Completed · 32 cited
  4. Phase 4 Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis Completed
  5. Phase 3 Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients Completed
  6. Phase 3 Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MONARCH) Completed
Show 9 more trials
  1. Phase 3 To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis Completed
  2. Phase 3 To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET) Completed
  3. Phase 3 A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA) Completed
  4. Phase 2 Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis Completed
  5. Phase 2 Sarilumab for Patients With Moderate COVID-19 Disease Completed
  6. Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis Completed
  7. Phase 2 An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA) Completed
  8. Phase 2 Sarilumab in Patients With Glucocorticoid-Dependent Sarcoidosis Completed
  9. Phase 2 Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic Mastocytosis Completed

Showing the 15 most-cited and recently-updated of 15 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.